Earnings Summary

GSK PLC-SPON ADR.’s revenue fell -28.93% since last year same period to $6951Mn in the Q1 2023. On a quarterly growth basis, GSK PLC-SPON ADR. has generated -5.76% fall in its revenue since last 3-months.

GSK PLC-SPON ADR.’s net profit fell -17.31% since last year same period to $1490Mn in the Q1 2023. On a quarterly growth basis, GSK PLC-SPON ADR. has generated -0.33% fall in its net profits since last 3-months.

GSK PLC-SPON ADR.’s net profit margin jumped 16.34% since last year same period to 21.44% in the Q1 2023. On a quarterly growth basis, GSK PLC-SPON ADR. has generated 5.76% jump in its net profit margins since last 3-months.

GSK PLC-SPON ADR.’s price-to-earnings ratio after this Q1 2023 earnings stands at 12.43.

GSK PLC-SPON ADR.’s earning per share (EPS) estimates for the current quarter stand at 0.88 - a 12.51% jump from last quarter’s estimates.

GSK PLC-SPON ADR.’s earning per share (EPS) estimates for the current year stand at 0.88.

GSK PLC-SPON ADR.’s earning per share (EPS) fell -100% since last year same period to 0 in the Q2 2023. This indicates that the GSK PLC-SPON ADR. has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

GSK PLC-SPON ADR. declared 0.35 dividend per share during the earnings announcement for Q2 2023.